相关实验视频

Updated: Jul 9, 2025

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

在A型急性大动脉剖析患者中风险分层的生物标志物

Kayo Yamamoto¹, Yuichi Saito¹, Osamu Hashimoto²

¹Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

The American journal of cardiology

|December 1, 2023

概括

对A型急性大动脉剖析 (AAD) 进行准确的风险分层至关重要. 这项研究发现,心脏特罗素,脑性尿素 (BNP) 和乳酸脱酶 (LDH) 的升高,以及总 bilirubin (T-Bil) 的降低,预测AAD患者的住院死亡率更高.

科学领域:

心血管医学心血管医学
生物标志物研究生物标志物研究
医学诊断医学诊断医学诊断

背景情况:

甲型急性大动脉解剖 (AAD) 是一种危及生命的疾病,需要精确的风险评估.
客观的风险分层对于指导AAD患者的治疗策略至关重要.
识别可访问的生物标志物可以改善患者管理和结果.

研究的目的:

评估A型AAD患者住院死亡率的常规可用生物标志物的预后价值.
确定生物标志物的组合是否可以增强风险分层.
探索这些生物标志物在临床决策中的有用性.

主要方法:

这是一项回顾性,多中心的观察性研究,包括703名A型AAD患者.
分析了15个循环生物标志物,这些生物标志物是在入院时测量的.
多变量分析和接收器运行特征 (ROC) 曲线分析以评估预测值.

主要成果:

在17.9%的患者 (703人中有126人) 观察到住院死亡率.
阳性心脏素,低总白血素 (T-Bil),脑内尿酸 (BNP) 的升高,乳酸脱酶 (LDH) 的升高是住院死亡的显著预测因素.
这四种生物标志物的组合显示出增量预后价值,死亡率随着阳性生物标志物的数量逐渐增加而逐渐增加.

结论:

阳性心脏热素,低T-Bil和升高的BNP和LDH水平与A型AAD的住院死亡率增加有关.
这些易于评估的生物标志物提供增量预后价值,并可以帮助治疗策略决策.
基于生物标志物的风险分层可能会改善A型AAD的管理.

关键词:

大脑的 natriuretic 酸.乳酸脱酶的使用方法总比利鲁宾的总量这种药物是热素 (troponin).一种类型的甲动脉剖析.

更多相关视频

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...